Summary by Moomoo AI
At the request of China China Pharmaceutical Holdings Limited, the Company's shares were briefly suspended on the Stock Exchange of Hong Kong Limited from 9.18am on Thursday, 8 February 2024. THIS DISCONTINUATION IS IN ORDER TO ISSUE AN ANNOUNCEMENT REGARDING THE COMPANY'S INSIDE INFORMATION, WHICH IS SUBJECT TO THE HONG KONG CODE OF ACQUISITIONS AND MERGERS, SECTION 13.09 (2) OF THE EXCHANGE LISTING RULES AND SECTION XIVA OF THE SECURITIES AND FUTURES ORDINANCE, CHAPTER 571 OF THE HONG KONG LAW. The Company's Board of Directors is composed of eleven directors, including Executive Directors Mr. Chen Ying Long, Mr. Ching Xue Yan and Mr. Yang Wenming, Non-Executive Directors Ms. Li Ju, Mr. Yang Binghua, Mr. Wang Luang and Mr. Meng Qingxin, as well as Independent Non-Executive Directors Mr. Xie Wing, Mr. Yu Zishan, Mr. Qin Ling and Mr. Lee Wai Dong。